Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00363_DB00502> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00363_DB00502 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00363_DB00502 label "DDI between Clozapine and Haloperidol - Clozapine, a moderate CYP2D6 inhibitor, may increase the serum concentration of haloperidol by decreasing its metabolism. Additive CNS despresant and anticholinergic effects may also occur. Monitor for changes in the therapeutic and adverse effects of haloperidol if clozapine is initiated, discontinued or dose changed. Also monitor for increased CNS depressant and anticholinergic effects during concomitant therapy. [drugbank_resource:DB00363_DB00502]" assertion.
- drugbank_resource:DB00363_DB00502 identifier "drugbank_resource:DB00363_DB00502" assertion.
- drugbank_resource:DB00363_DB00502 title "DDI between Clozapine and Haloperidol - Clozapine, a moderate CYP2D6 inhibitor, may increase the serum concentration of haloperidol by decreasing its metabolism. Additive CNS despresant and anticholinergic effects may also occur. Monitor for changes in the therapeutic and adverse effects of haloperidol if clozapine is initiated, discontinued or dose changed. Also monitor for increased CNS depressant and anticholinergic effects during concomitant therapy." assertion.